| Pfizer AG - Vfend 50 mg, Filmtabletten | | 55946 | | 01 | | Vfend 50 mg | | Filmtabletten | | J02AC03 | | Voriconazole | | 29.10.2002 | | |
| | Composition | | voriconazolum 50 mg, lactosum monohydricum 62.5 mg, amylum pregelificatum, carmellosum natricum conexum corresp. natrium 1.41 mg, povidonum K 30, magnesii stearas, Überzug: hypromellosum, lactosum monohydricum 0.919 mg, triacetinum, E 171, pro compresso obducto. | | Packungsbestandteile | | Coated tablets | | | | | Active Agent | Dose |
|---|
| Voriconazole | 50 mg |
| | BAG: Active Agent | Dose |
|---|
| Voriconazole | 50 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| Amylum Pregelificatum | | | | Carmellosum Natricum Conexum | | | | E 171 | | color. | | Hypromellosum | | Überzug | | Lactose Monohydrate | 0.919 mg | | | Magnesii Stearas | | | | Povidonum K | 30 | | | Pro Compresso Obducto | | | | Triacetinum | | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 56 Tablet(s) | 505.45 | 562.40 | A | SL | No |
|
|
